Navigation Links
World's largest lung cancer screening conference to address benefits of CT scans
Date:2/18/2011

Who: The world's leading lung cancer screening researchers, doctors and advocates. The International Lung Cancer Consortium (ILCCO) and International Early Lung Cancer Action Program (I-ELCAP) Screening Conferences.

What: The 24th Annual Meeting of the International Early Lung Cancer Action Program (I-ELCAP) and the first joint conference between I-ELCAP and the International Lung Cancer Consortium (ILCCO). This meeting between I-ELCAP and ILCCO represents the largest conference on lung cancer screening in the world and will demonstrate the collaborative efforts of cancer centers and medical institutions in 26 states and eight countries whose mission is to reduce deaths from lung cancer by early detection and diagnosis through screening by computed tomography (CT).

Where: Scottsdale McCormick Ranch, Scottsdale, Ariz.

When: Friday, Feb. 25 and Saturday, Feb. 26.

Why: A recent study by the National Cancer Institute (NCI) confirmed I-ELCAP results that CT screening can find lung cancers in the earliest, most curable stage, significantly reducing the number of deaths from this deadly disease. I-ELCAP leaders and conference hosts Drs. Claudia Henschke and David Yankelevitz, who hold appointments as research scientist at the Arizona State University Biodesign Institute and are physicians at Mount Sinai Medical Center in New York, have dedicated their lives to researching the impact of CT screening for high-risk lung cancer patients. Their research found that with CT scanning, more than 80 percent of lung cancers are detected in Stage 1, when they are highly curable. CT scanning for lung cancer holds the promise of saving tens of thousands of lives, not to mention millions of dollars.

The ongoing I-ELCAP study, based on a common CT screening protocol, collects scientific data at various research sites worldwide. More than 54,000 high risk patients have been screened thus far, making it the largest lung cancer screening study of its kind. The data is pooled with worldwide collaborators and contributes to their ongoing research regarding best practices for CT screening.

This conference represents a premier media opportunity to learn more about early detection efforts to save lives for those afflicted with lung cancer--- the No. 1 cancer killer in the world. Among the topics discussed at the conference will be:

  • Understanding the results of NCI's National Lung Screening Trial
  • Minimizing harms related to screening
  • Development of future collaborative lung cancer screening research
  • The cost-effectiveness of lung cancer screening


'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert

Related medicine news :

1. Gunther von Hagens BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo
2. Anthropologist: Body Worlds visitors confront bodies but not death
3. EdenHome.com Adds Aventura Organic Clothes to Site and Announces Largest Online Selection of Stylish Organic Clothes for Men, Women and Children
4. Psychologists Say New Jerseys Largest Health Plan Violates Patient Privacy, Restricts Access to Care and Wastes Taxpayer Money
5. Biocell Center Corporation Partners with New Englands Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation
6. DTM Systems Corporation Ranked Number One as the Largest Reseller in British Columbia to Hewlett Packard Canada
7. M. D. Anderson receives 4.5 million grant, largest ever for study of yoga and cancer
8. CA Dental Hygienists' Association to Provide Care to Thousands of Uninsured at Southland's Largest Free Public Health Clinic
9. Worlds largest polar science conference to take place in Oslo
10. Largest Internet Supplier of Eternity Rings Pledges 10% of their Profits to the National Breast Cancer Foundation
11. Vitamin D Best Taken With Largest Meal of Day, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: